965 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Not yet recruiting Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
Condition: Bronchial Cancer
Intervention: Device: With and without SDB
4 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
5 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
6 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
7 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
8 Not yet recruiting Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer
Conditions: Melanoma;   Non-small Cell Lung Cancer;   Brain Metastasis
Intervention: Drug: Pembrolizumab plus Bevacizumab
9 Recruiting Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Olaparib;   Drug: Placebo
10 Not yet recruiting Prospective Observational Study To Identify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) And ALK Translocation And To Establish Their Therapeutic Management (IDEALK)
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Crizotinib
11 Not yet recruiting Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer
Conditions: Carcinoma, Small Cell;   Lung Neoplasms
Interventions: Radiation: high-dose TRT;   Radiation: standard-dose TRT
12 Recruiting Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer (TRINITY)
Condition: Small Cell Lung Cancer
Intervention: Drug: Rovalpituzumab tesirine
13 Not yet recruiting Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Biological: durvalumab;   Biological: bavituximab
14 Not yet recruiting Study of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLC
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: Dabrafenib;   Drug: Trametinib
15 Not yet recruiting LUME BioNIS: a Biomarker Study in Patients With NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Intervention:
16 Recruiting Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer
Condition: Carcinoma, Non-small Cell Lung
Interventions: Genetic: Genomic profile by FoundationOne;   Genetic: Genomic profile by other methods
17 Not yet recruiting MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
Conditions: Non-Small Cell Lung Cancer;   Nonsmall Cell Lung Cancer;   Breast Cancer;   Cancer of Breast;   Cancer of the Breast;   Gastroesophageal Cancer;   Pancreatic Cancer;   Cancer of the Pancreas;   Colorectal Cancer;   Colorectal Carcinoma;   Renal Cancer;   Kidney Cancer;   Cancer of the Kidney;   Cancer of Kidney;   Ovarian Cancer;   Ovary Cancer;   Cancer of the Ovary;   Cancer of Ovary
Intervention: Drug: MEDI4736
18 Recruiting Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC
Condition: Non Small Cell Lung Cancer
Interventions: Biological: chemotherapy followed dendritic cells;   Drug: pemetrexed and carboplatin
19 Not yet recruiting Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Docetaxel;   Drug: Nintedanib
20 Recruiting Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC
Condition: Non-Small Cell Lung Cancer(NSCLC)
Interventions: Drug: Paclitaxel Micelles for Injection;   Drug: Paclitaxel Injection;   Drug: Cisplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years